BioCentury
ARTICLE | Finance

Ebb & Flow

November 3, 2008 8:00 AM UTC

Cardiovascular and pulmonary company Dyax (NASDAQ:

DYAX) has found a bevy of ways to bring in cash this year, despite the poor funding environment. Its latest move was to set up a $50 million committed equity financing facility (CEFF) with Azimuth Opportunity last week...